Sunquest Announces Roper Technologies’ Acquisition of CliniSys and Atlas Medical
News Nov 02, 2015
Sunquest Information Systems Inc. announced that its parent company, Roper Technologies Inc., has entered into definitive agreements to acquire both CliniSys Group Ltd., one of the largest European suppliers of laboratory information management systems (LIMS) and Atlas Medical, a leading provider of clinical process and connectivity solutions in the U.S..
These acquisitions, combined with Sunquest and Data Innovations, expand Roper’s portfolio of companies focused on diagnostic solutions excellence even further, creating a unique breadth of capabilities that support clinical testing processes and connectivity to systems, instruments and providers across the world.
“Our mission is to make healthcare smarter and patients safer. Laboratory test results inform the vast majority of patient diagnoses and care planning. As more patient care moves outside of the hospital, communities need access to lab information to accurately, cost-effectively and quickly provide patient care,” said Matthew Hawkins, president of Sunquest. “Sunquest, Data Innovations, CliniSys and Atlas share the same vision in creating solutions that promote patient safety, better outcomes, operational efficiency and financial growth.”
CliniSys is one of the largest European suppliers of laboratory information systems, providing comprehensive clinical laboratory and order communication systems to more than 2,000 laboratories in 34 countries. Completion of the CliniSys acquisition is dependent upon receiving approval from the competition authorities in Germany and the United Kingdom. Collaboration between Sunquest and CliniSys will not begin until formal approval is received.
“We have admired Roper’s and Sunquest’s growth and achievements in clinical solutions. Their market presence aligns perfectly with where we want to be on an international scale, and their passion for diagnostic solutions matches our own. We are excited and confident that this is the right move strategically for both our clients and employees,” said Fiona Pearson, chief executive officer of CliniSys Group.
Atlas offers clinical process integration and connectivity solutions. Atlas’s LabWorks platform connects diagnostic testing facilities to their customers and enables smart ordering, dramatically improved test utilization, and results reporting. Atlas also connects physicians and patients with lab test results via Atlas Physician Portal. Atlas is the industry leader in connecting laboratories to electronic health records (EHRs), Accountable Care Organizations (ACOs) and Health Information Exchanges (HIEs).
“Atlas is proud to be the newest member of the Roper family,” said Rob Atlas, chief executive officer of Atlas Medical. “Together with Sunquest and Data Innovations, we can connect community care givers with laboratories equipped with the most advanced clinical capabilities on the market.”
The companies will explore opportunities to use their respective technologies and employees to provide new products and benefits to customers. The acquisitions were announced on the October 26, 2015 Roper earnings call.
HIV-1 replicates in ninja-like ways. The virus slips through the membrane of vital white blood cells. Inside, HIV-1 copies its genes and scavenges parts to build a protective bubble for its copies. Now, supercomputers have helped model a key building block in the HIV-1 protective capsid, which could lead to strategies for potential therapeutic intervention in HIV-1 replication.READ MORE
Mood disorders like major depressive disorder (MDD) and bipolar disorder are often complex and hard to diagnose, especially among youth when the illness is just evolving. This can make decisions about medication difficult. In a collaborative study by Lawson Health Research Institute, The Mind Research Network and Brainnetome Center, researchers have developed an artificial intelligence (AI) algorithm that analyzes brain scans to better classify illness in patients with a complex mood disorder and help predict their response to medication.